tripterygium wilfordii

DRUG4 trials

Sponsors

Zhi-Hong Liu, M.D., Peking Union Medical College Hospital

Conditions

Arthritis, RheumatoidIdiopathic Membranous NephropathyIgG4 Related DiseasePolycystic Kidney

Phase 2

Tripterygium Wilfordii Plus Prednisone for Active IgG4-Related Disease

Not yet recruitingNCT07878585

Peking Union Medical College HospitalIgG4 Related Disease

Start: 2026-09-01End: 2028-11-01Target: 74Updated: 2026-10-16

Phase 4

Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA

CompletedNCT03589833

Peking Union Medical College HospitalArthritis, Rheumatoid

Start: 2019-05-14End: 2022-07-27Updated: 2022-10-25

Unknown Phase

Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease

TerminatedNCT00801268

Zhi-Hong Liu, M.D.Polycystic Kidney

Start: 2008-11-30End: 2013-11-30Updated: 2015-03-30

Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid

CompletedNCT01161459

Zhi-Hong Liu, M.D.Idiopathic Membranous Nephropathy

Start: 2010-06-30End: 2013-10-31Target: 100Updated: 2014-06-02

Related Papers

Efficacy and safety of tripterygium wilfordii Hook F plus TNF inhibitor for active rheumatoid arthritis: A multicentre, randomized, double-blind, triple-dummy controlled trial.

2023-08-304 citations